A prospective non-inferiority study of Different bupivacaine concentrations in Erector spinae plane block during hepatic tumor ablation

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202109777479068

Enrollment

Registered

2021-09-08

Start date

2021-09-15

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaesthesia

Interventions

Group L

Grup C

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Adult patients, of either gender, with a Child-Pugh score not more than B and scheduled for ultrasound-guided PRFA of primary or secondary hepatic tumors a single focal hepatic lesion will be enrolled in the study.

Exclusion criteria

Exclusion criteria: Patients with an INR value exceeding 1.5, platelet count less than 50,000/mm3, body mass index (BMI)>35, history of mental disorders or psychiatric illness, those with chronic pain or on regular remedies of analgesics, allergy to local anesthetics and spine deformity will be excluded from the study

Design outcomes

Primary

Measure	Time frame
Post-procedural pain	—

Secondary

Measure	Time frame
analgesic consumption	—

Countries

Egypt

Contacts

Public ContactAlrefaey Alrefaey

Assistant lecturer of anesthesia

refa3ey2@yahoo.com+201064203475

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026